Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
13.50
+0.14 (1.05%)
At close: Mar 18, 2026, 4:00 PM EDT
13.56
+0.06 (0.44%)
After-hours: Mar 18, 2026, 7:35 PM EDT
Erasca Employees
Erasca had 103 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
103
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,209,184
Market Cap
4.20B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 0 | - |
| Dec 31, 2024 | 103 | -23 | -18.25% |
| Dec 31, 2023 | 126 | -3 | -2.33% |
| Dec 31, 2022 | 129 | 6 | 4.88% |
| Dec 31, 2021 | 123 | 21 | 20.59% |
| Jun 30, 2021 | 102 | - | - |
| Mar 31, 2021 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Crinetics Pharmaceuticals | 594 |
| Amicus Therapeutics | 511 |
| TG Therapeutics | 399 |
| CRISPR Therapeutics AG | 393 |
| Scholar Rock Holding | 289 |
| Apogee Therapeutics | 261 |
| Structure Therapeutics | 220 |
| Centessa Pharmaceuticals | 114 |
ERAS News
- 6 days ago - Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results - GlobeNewsWire
- 8 days ago - Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau - GlobeNewsWire
- 13 days ago - Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat - GlobeNewsWire
- 22 days ago - Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001 - GlobeNewsWire
- 5 weeks ago - Erasca to Present at Upcoming Conferences in February - GlobeNewsWire
- 7 weeks ago - Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday? - Benzinga
- 7 weeks ago - Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 2 months ago - Erasca Announces Pricing of Upsized Public Offering of Common Stock - GlobeNewsWire